| scholarly article | Q13442814 |
| P50 | author | Nynke Rots | Q108531517 |
| David Goldblatt | Q51053608 | ||
| Elisabeth Sanders | Q104749029 | ||
| P2093 | author name string | Guy A M Berbers | |
| Irina Tcherniaeva | |||
| Elske J M van Gils | |||
| Germie P J M van den Dobbelsteen | |||
| Lucy Cowell | |||
| Gerwin D Rodenburg | |||
| Els van Westen | |||
| P2860 | cites work | Burden of disease caused by Streptococcus pneumoniae in children younger than 5 years: global estimates | Q28258300 |
| Effectiveness of seven-valent pneumococcal conjugate vaccine against invasive pneumococcal disease: a matched case-control study | Q28270868 | ||
| Kinetics and avidity of antibodies evoked by heptavalent pneumococcal conjugate vaccines PncCRM and PncOMPC in the Finnish Otitis Media Vaccine Trial | Q33557154 | ||
| Evaluation of pneumococcal polysaccharide immunoassays using a 22F adsorption step with serum samples from infants vaccinated with conjugate vaccines | Q33613509 | ||
| Relationship between cell surface carbohydrates and intrastrain variation on opsonophagocytosis of Streptococcus pneumoniae. | Q33867105 | ||
| Efficacy, safety and immunogenicity of heptavalent pneumococcal conjugate vaccine in children. Northern California Kaiser Permanente Vaccine Study Center Group | Q33896897 | ||
| Functional characterization of human IgG, IgM, and IgA antibody directed to the capsule of Haemophilus influenzae type b. | Q34180479 | ||
| Effects of pneumococcal conjugate vaccine 2 years after its introduction, the Netherlands | Q34194058 | ||
| Serological criteria for evaluation and licensure of new pneumococcal conjugate vaccine formulations for use in infants | Q34205630 | ||
| Serotype-related variation in susceptibility to complement deposition and opsonophagocytosis among clinical isolates of Streptococcus pneumoniae | Q34309712 | ||
| Use of opsonophagocytosis for serological evaluation of pneumococcal vaccines | Q34429349 | ||
| Older Adults Have a Low Capacity To Opsonize Pneumococci Due to Low IgM Antibody Response to Pneumococcal Vaccinations | Q34484625 | ||
| Pediatric invasive pneumococcal disease caused by vaccine serotypes following the introduction of conjugate vaccination in Denmark | Q34568186 | ||
| Enzyme-linked immunosorbent assay for quantitation of human antibodies to pneumococcal polysaccharides | Q35139987 | ||
| Functional antibodies elicited by two heptavalent pneumococcal conjugate vaccines in the Finnish Otitis Media Vaccine Trial | Q35783918 | ||
| Serum IgM antibodies contribute to high levels of opsonophagocytic activities in toddlers immunized with a single dose of the 9-valent pneumococcal conjugate vaccine | Q36362202 | ||
| 10-valent pneumococcal nontypeable Haemophilus influenzae PD conjugate vaccine: Synflorix. | Q37622887 | ||
| Comparing pneumococcal conjugate vaccine schedules based on 3 and 2 primary doses: systematic review and meta-analysis | Q37912703 | ||
| 13-valent pneumococcal conjugate vaccine (PCV13). | Q37937371 | ||
| Effect of reduced-dose schedules with 7-valent pneumococcal conjugate vaccine on nasopharyngeal pneumococcal carriage in children: a randomized controlled trial | Q38380351 | ||
| Development and validation of a fourfold multiplexed opsonization assay (MOPA4) for pneumococcal antibodies | Q41902347 | ||
| Effectiveness of the ten-valent pneumococcal Haemophilus influenzae protein D conjugate vaccine (PHiD-CV10) against invasive pneumococcal disease: a cluster randomised trial | Q42286179 | ||
| Invasive pneumococcal disease in the Netherlands: Syndromes, outcome and potential vaccine benefits | Q43878386 | ||
| Comparability of antibody response to a booster dose of 7-valent pneumococcal conjugate vaccine in infants primed with either 2 or 3 doses | Q43962182 | ||
| Pneumococcal 13-valent conjugate vaccine for the prevention of invasive pneumococcal disease in children and adults. | Q44398866 | ||
| Long-term effect of pneumococcal conjugate vaccine on nasopharyngeal colonization by Streptococcus pneumoniae--and associated interactions with Staphylococcus aureus and Haemophilus influenzae colonization--in HIV-Infected and HIV-uninfected childre | Q44702826 | ||
| Challenges in the evaluation and licensing of new pneumococcal vaccines, 7-8 July 2008, Ottawa, Canada | Q44815058 | ||
| Immunogenicity and boosting after a reduced number of doses of a pneumococcal conjugate vaccine in infants and toddlers | Q44962366 | ||
| A trial of a 9-valent pneumococcal conjugate vaccine in children with and those without HIV infection | Q46198228 | ||
| Avidity of IgG for Streptococcus pneumoniae type 6B and 23F polysaccharides in infants primed with pneumococcal conjugates and boosted with polysaccharide or conjugate vaccines | Q48023963 | ||
| Immunogenicity of the 10-valent pneumococcal non-typeable Haemophilus influenzae protein D conjugate vaccine (PHiD-CV) compared to the licensed 7vCRM vaccine. | Q51748961 | ||
| Maintaining protection against invasive bacteria with protein-polysaccharide conjugate vaccines. | Q51824053 | ||
| Immunological memory: the role of B cells in long-term protection against invasive bacterial pathogens. | Q51985495 | ||
| Ability of 3 different meningococcal C conjugate vaccines to induce immunologic memory after a single dose in UK toddlers. | Q52023272 | ||
| The Changing Epidemiology of Invasive Pneumococcal Disease in Aboriginal and Non‐Aboriginal Western Australians from 1997 through 2007 and Emergence of Nonvaccine Serotypes | Q57635546 | ||
| Contribution of serotype-specific IgG concentration, IgG subclasses and relative antibody avidity to opsonophagocytic activity against Streptococcus pneumoniae | Q73264844 | ||
| Natural development of antibodies to pneumococcal capsular polysaccharides depends on the serotype: association with pneumococcal carriage and acute otitis media in young children | Q74332994 | ||
| Pneumococcal polysaccharide-protein CRM197 conjugate vaccines, 7- or 9-valent, in the 2 + 1 schedule | Q83703086 | ||
| The effect of an alternative reduced-dose infant schedule and a second year catch-up schedule with 7-valent pneumococcal conjugate vaccine on pneumococcal carriage: a randomized controlled trial | Q84344058 | ||
| P433 | issue | 49 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | pneumococcal conjugate vaccine | Q7205991 |
| P304 | page(s) | 5834-5842 | |
| P577 | publication date | 2013-10-10 | |
| P1433 | published in | Vaccine | Q7907941 |
| P1476 | title | Levels and functionality of antibodies after pneumococcal conjugate vaccine in schedules with different timing of the booster dose | |
| P478 | volume | 31 |
| Q47196815 | Differences by sex in IgG levels following infant and childhood vaccinations: An individual participant data meta-analysis of vaccination studies |
| Q30238724 | From Immunologically Archaic to Neoteric Glycovaccines |
| Q38372299 | Pneumococcal conjugate vaccination response in patients after community-acquired pneumonia, differences in patients with S. pneumoniae versus other pathogens. |
Search more.